Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-19
DOI
10.3389/fphys.2017.00508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells
- (2016) Hong Yang et al. BIOMATERIALS
- Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4
- (2016) Linda Foit et al. BIOMATERIALS
- Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
- (2016) E Monnet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update
- (2016) Y H Lee et al. LUPUS
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Amino Acid-Dependent Attenuation of Toll-like Receptor Signaling by Peptide-Gold Nanoparticle Hybrids
- (2015) Hong Yang et al. ACS Nano
- Toll-like receptors: potential targets for lupus treatment
- (2015) Yan-wei Wu et al. ACTA PHARMACOLOGICA SINICA
- Toll-like receptor 9 plays a key role in the autonomic cardiac and baroreflex control of arterial pressure
- (2015) Fernanda Luciano Rodrigues et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine
- (2015) E. Monnet et al. ANNALS OF THE RHEUMATIC DISEASES
- Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension
- (2015) R Hernanz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats
- (2015) Cameron G. McCarthy et al. CARDIOVASCULAR RESEARCH
- Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation
- (2015) Yanwei Wu et al. Cellular & Molecular Immunology
- Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response
- (2015) Dan Hu et al. CELLULAR IMMUNOLOGY
- Enhancing the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using lipid nanoparticle systems
- (2015) Paulo JC Lin et al. Future Medicinal Chemistry
- Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release
- (2015) Jargalsaikhan Dagvadorj et al. IMMUNITY
- Endosomal Toll-like receptors in clinically overt and silent autoimmunity
- (2015) Robert M. Clancy et al. IMMUNOLOGICAL REVIEWS
- Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats
- (2015) G.F. Bomfim et al. LIFE SCIENCES
- Toll-like receptor signalling through macromolecular protein complexes
- (2015) Clare E. Bryant et al. MOLECULAR IMMUNOLOGY
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis
- (2015) Cristiano Xavier Lima et al. PLoS One
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
- (2015) Pedro Pedrosa et al. Nanomaterials
- Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells
- (2015) Franziska Römmler et al. PLoS One
- Protective Role for Toll-Like Receptor-9 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2014) Christine Koulis et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Chronic Hydroxychloroquine Improves Endothelial Dysfunction and Protects Kidney in a Mouse Model of Systemic Lupus Erythematosus
- (2014) Manuel Gómez-Guzmán et al. HYPERTENSION
- Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4–NF-κB signaling
- (2014) Hasan Babazada et al. JOURNAL OF CONTROLLED RELEASE
- Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4–NF-κB signaling
- (2014) Hasan Babazada et al. JOURNAL OF CONTROLLED RELEASE
- Opposing Impact of B Cell-Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation
- (2014) S. W. Jackson et al. JOURNAL OF IMMUNOLOGY
- Trehalose- and Glucose-Derived Glycoamphiphiles: Small-Molecule and Nanoparticle Toll-Like Receptor 4 (TLR4) Modulators
- (2014) Julio Rodriguez Lavado et al. JOURNAL OF MEDICINAL CHEMISTRY
- Toll-Like Receptors and Ischemic Brain Injury
- (2014) Raffaella Gesuete et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Chloroquine use improves dengue-related symptoms
- (2014) Marcos Carvalho Borges et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: Ethnic differences and potential new targets for therapeutic drugs
- (2014) Beverly D. Lyn-Cook et al. MOLECULAR IMMUNOLOGY
- MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways
- (2014) Xiaobing He et al. Biomed Research International
- Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
- (2014) Teja Celhar et al. Frontiers in Pharmacology
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension
- (2013) Cameron G. McCarthy et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques
- (2013) Minako Ishibashi et al. ATHEROSCLEROSIS
- Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation
- (2013) Lei Wang et al. CARDIOVASCULAR RESEARCH
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
- (2013) Steven M. Opal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High Density Lipoprotein Protects against Polymicrobe-induced Sepsis in Mice
- (2013) Ling Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- Guanine Modification of Inhibitory Oligonucleotides Potentiates Their Suppressive Function
- (2013) F. Rommler et al. JOURNAL OF IMMUNOLOGY
- The TLR4 antagonist Eritoran protects mice from lethal influenza infection
- (2013) Kari Ann Shirey et al. NATURE
- Small Interfering RNA Targeting Toll-Like Receptor 9 Protects Mice against Polymicrobial Septic Acute Kidney Injury
- (2013) Lixia Liu et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Chloroquine pretreatment inhibits toll-like receptor 3 signaling after stroke
- (2013) Guiyun Cui et al. NEUROSCIENCE LETTERS
- Amino Acid Structure Determines the Immune Responses Generated by Peptide-Gold Nanoparticle Hybrids
- (2013) Hong Yang et al. PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
- Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation
- (2013) Mayte Suárez-Fariñas et al. PLoS One
- Hydrocortisone Reduces the Beneficial Effects of Toll-Like Receptor 2 Deficiency on Survival in a Mouse Model of Polymicrobial Sepsis
- (2013) Stefan Bergt et al. SHOCK
- Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
- (2012) Fatih Arslan et al. Circulation-Cardiovascular Interventions
- MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice
- (2012) Yang Pan et al. International Journal of Nanomedicine
- MicroRNAs—novel regulators of systemic lupus erythematosus pathogenesis
- (2012) Nan Shen et al. Nature Reviews Rheumatology
- Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptors
- (2012) Altaf-M. Khan et al. PEPTIDES
- Toll-Like Receptor 7 Preconditioning Induces Robust Neuroprotection Against Stroke by a Novel Type I Interferon-Mediated Mechanism
- (2012) Philberta Y. Leung et al. STROKE
- Programming the Cellular Uptake of Physiologically Stable Peptide-Gold Nanoparticle Hybrids with Single Amino Acids
- (2011) Hong Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses
- (2011) Li-Fei Hou et al. ARTHRITIS AND RHEUMATISM
- Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke
- (2011) David Brea et al. CLINICAL IMMUNOLOGY
- Toll-like receptors
- (2011) Eva Marie Y. Moresco et al. CURRENT BIOLOGY
- The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy
- (2011) Heidi Ehrentraut et al. EUROPEAN JOURNAL OF HEART FAILURE
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
- (2011) Amisha Barochia et al. Expert Opinion on Drug Metabolism & Toxicology
- Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury
- (2011) Conrad A. Farrar et al. FASEB JOURNAL
- A trio of microRNAs that control Toll-like receptor signalling
- (2011) S. R. Quinn et al. INTERNATIONAL IMMUNOLOGY
- miR-146ais a significant brake on autoimmunity, myeloproliferation, and cancer in mice
- (2011) Mark P. Boldin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- Toll-like receptors in cerebral ischemic inflammatory injury
- (2011) Yan-Chun Wang et al. Journal of Neuroinflammation
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
- (2011) Nicholas I Paton et al. LANCET INFECTIOUS DISEASES
- Targeting of Toll-like receptors: a decade of progress in combating infectious diseases
- (2011) Mona Hedayat et al. LANCET INFECTIOUS DISEASES
- Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization
- (2011) Min Chen et al. MOLECULAR IMMUNOLOGY
- The role of antimalarial agents in the treatment of SLE and lupus nephritis
- (2011) Senq-J Lee et al. Nature Reviews Nephrology
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
- (2011) Sinéad Nic An Ultaigh et al. ARTHRITIS RESEARCH & THERAPY
- Ambient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for traffic-related asthma flares
- (2010) Ning Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient Mice
- (2010) Mie Higashimori et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
- (2010) A. Komatsuda et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
- (2010) S. K. Libutti et al. CLINICAL CANCER RESEARCH
- A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
- (2010) Todd W. Rice et al. CRITICAL CARE MEDICINE
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
- (2010) Ryan M. O'Connell et al. IMMUNITY
- Blocking TLR2 in vivo Protects against Accumulation of Inflammatory Cells and Neuronal Injury in Experimental Stroke
- (2010) Gina Ziegler et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Toll-like receptor 4 in CNS pathologies
- (2010) Madison M. Buchanan et al. JOURNAL OF NEUROCHEMISTRY
- Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus
- (2010) A. Lesiak et al. LUPUS
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
- (2010) Cristiana Guiducci et al. NATURE
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients
- (2010) Federica Capolunghi et al. RHEUMATOLOGY
- Protective Effects of Toll-like Receptor 4 Inhibitor Eritoran on Renal Ischemia-Reperfusion Injury
- (2010) M. Liu et al. TRANSPLANTATION PROCEEDINGS
- A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis
- (2009) Ryan Ungaro et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
- (2009) Yuanjia Tang et al. ARTHRITIS AND RHEUMATISM
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis
- (2009) Claudia Monaco et al. CIRCULATION
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*
- (2009) Mark Tidswell et al. CRITICAL CARE MEDICINE
- Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor
- (2009) E. Mortaz et al. EUROPEAN RESPIRATORY JOURNAL
- The role of Toll-like receptors in chronic inflammation
- (2009) Stefan K. Drexler et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Different Doses of Lipopolysaccharides Regulate the Lung Inflammation of Asthmatic Mice via TLR4 Pathway in Alveolar Macrophages
- (2009) Liang Dong et al. JOURNAL OF ASTHMA
- Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus
- (2009) A. Lartigue et al. JOURNAL OF IMMUNOLOGY
- Valsartan preconditioning protects against myocardial ischemia–reperfusion injury through TLR4/NF-κB signaling pathway
- (2009) Jian Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
- (2009) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
- (2009) L. A. J. O'Neill et al. PHARMACOLOGICAL REVIEWS
- Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
- (2009) T. Roger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells
- (2009) Maurizio Ceppi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
- (2009) D. H. Kono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
- (2008) Mohan R. Dasu et al. ATHEROSCLEROSIS
- TLRs and innate immunity
- (2008) B. A. Beutler BLOOD
- The influence of antimalarial treatment on IL-1β, IL-6 and TNF-α mRNA expression on UVB-irradiated skin in systemic lupus erythematosus
- (2008) A. Wozniacka et al. BRITISH JOURNAL OF DERMATOLOGY
- Pattern recognition receptors and control of adaptive immunity
- (2008) Noah W. Palm et al. IMMUNOLOGICAL REVIEWS
- Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers
- (2008) Daniel P. Rossignol et al. Innate Immunity
- TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events
- (2008) Karen A. Cavassani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
- (2008) Adam E. Mullick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus
- (2008) Pui Y. Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
- (2008) Stephan Spiller et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of Toll-like receptors in gastrointestinal malignancies
- (2008) M Fukata et al. ONCOGENE
- Enhanced immediate inflammatory response to Streptococcus pneumoniae in the lungs of mice with pulmonary emphysema
- (2008) Yoshikane TOKAIRIN et al. RESPIROLOGY
- Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
- (2007) Gábor Földes et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started